Results 171 to 180 of about 28,989 (238)

Cardiorenal Biomarkers and their Implications in Prognosis and Treatment Response of Transthyretin Cardiac Amyloidosis. [PDF]

Curr Heart Fail Rep
Jefferson A, Narvekar P, Roehm B, Toto R, Roth L, Grodin JL.   +5 more
europepmc   +1 more source

Effect of Eplontersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy Across Genetic Variants: An Exploratory Analysis From the NEURO-TTRansform Trial. [PDF]

Eur J Neurol
Gillmore JD, Adams D, Weiler M, Masri A, Obici L, Nåtman J, Kwoh TJ, Reicher B, Revkin J, Cruz MW, Gertz M, Chao CC.   +11 more
europepmc   +1 more source

Efficacy of Acoramidis in Adults With Transthyretin Amyloid Cardiomyopathy: Propensity Score Comparison Between a Single-Arm Open-Label Phase 3 Trial in Japan and a Global Double-Blind Phase 3 Trial. [PDF]

Circ Rep
Tahara N, Raizner A, Chen Y, Mercuri MF, Minamisawa M, Phase 3 Japan Study Investigators.   +5 more
europepmc   +1 more source

Exploring the MicroRNA Landscape in Cardiac Amyloidosis: Molecular Insights and Clinical Applications. [PDF]

Genes (Basel)
Kontaraki JE, Plevritaki A, Sallo A, Fragkiadakis K, Kallergis E, Zacharis E, Kopidakis J, Kampanieris E, Achladianaki S, Papakosta V, Simantirakis E, Marketou ME.   +11 more
europepmc   +1 more source

Targeting transthyretin deposition in lumbar spinal stenosis: a mechanistic rationale for tafamidis. [PDF]

Front Surg
González IZ, Ureña G.
europepmc   +1 more source

Low-dose ventricular radiotherapy in wild-type transthyretin cardiac amyloidosis: a prospective, first-in-human, exploratory clinical trial. [PDF]

Int J Cardiol Heart Vasc
Guijarro D, Massie E, Zilli T, Beale A, Garibotto V, Nkoulou R, Meyer P.   +6 more
europepmc   +1 more source

Patient Perspectives on Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Attributes. [PDF]

Cardiol Ther
Kumar N, Coulter J, Haddad-Angulo A, Baig L, Chung H, Chandrasekar SM, Vass C, Galinsky J, Carr AM, McIntosh K, Hauber B.   +10 more
europepmc   +1 more source

Therapeutic Efficacy and Safety Profile of Eplontersen in Hereditary Transthyretin-Mediated Amyloidosis: A Systematic Review. [PDF]

Health Sci Rep
Patel ZV, Kumari V, Paras, Deepak BL, Prajjwal P, Deep KN, Bai R, John SS, Hussin OA.   +8 more
europepmc   +1 more source

Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study. [PDF]

Front Nucl Med
Tingen HSA, Stormezand GN, van Snick P, Hu Y, Van Der Zwaag P, Oerlemans M, van der Meer P, Hazenberg BPC, Luurtsema G, Nienhuis HLA, Slart RHJA.   +10 more
europepmc   +1 more source